Zenotech Laboratories is currently trading at Rs 41.90, up by 1.95 points or 4.88% from its previous closing of Rs 39.95 on the BSE.
The scrip opened at Rs. 41.90 and has touched a high and low of Rs. 41.90 and Rs. 41.90 respectively. So far 2800 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 61.45 on 07-Jan-2016 and a 52 week low of Rs. 30.05 on 17-Jun-2015.
Last one week high and low of the scrip stood at Rs. 39.95 and Rs. 33.70 respectively. The current market cap of the company is Rs. 144.25 crore.
The promoters holding in the company stood at 66.85% while Institutions and Non-Institutions held 0.01% and 33.14% respectively.
Zenotech Laboratories has decided to raise funds through a rights issue to its existing shareholders. The company's Board of Directors have considered and approved the raising of funds by way of offer and issue of equity shares to the existing shareholders of the company on a rights basis. The Board has constituted a Committee of Directors (the Committee) for the said purpose and has authorised the Committee to determine the terms of the Rights Issue including the quantum of issue, rights entitlement ratio, issue price, issue size, book closure or record date, entitlement, timing of the issue, etc., in consultation with the Lead Manager to the Right Issue and to decide all other matters relating to the Right Issue.
The said proposal to issue of shares shall be subject to necessary approvals, confirmations and consents as may be necessary and in compliance with applicable law including the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and the Companies Act, 2013 and the Rules made there under.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1791.25 |
| Dr. Reddys Lab | 1218.10 |
| Cipla | 1493.05 |
| Lupin | 2066.35 |
| Zydus Lifesciences | 950.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
Become a savvy and confident
stock investor.
Don't miss out! First 10 users today get it FREE
Download APP
